Is AbbVie Inc. (ABBV) One of the Best Cancer Stocks to Invest In Now?

AbbVie (NYSE:ABBV) is one of the best cancer stocks to invest in now. On February 23, AbbVie (NYSE: ABBV) announced plans to invest $380 million to build two new active pharmaceutical ingredient manufacturing facilities. The new state-of-the-art facilities at the Illinois campus are to integrate advanced manufacturing technologies with artificial intelligence.

Artificial intelligence integration is part of AbbVie’s push to support and accelerate the development of next-generation neurosciences and obesity medications. Construction of the facilities is scheduled to begin in spring 2026 and come online in 2029. The construction of the state-of-the-art facility is part of the company’s $100 billion commitment towards research and development in the US.

“By strengthening our U.S. manufacturing capabilities, we are well-positioned to support our investment in innovation and enhance our ability to deliver next-generation medicines to patients,” said Robert A. Michael, chairman and chief executive officer, AbbVie.

AbbVie has already reiterated its plans to expand its manufacturing capabilities and capacity in the US. It has already broken ground on the first phase of the investment, with plans for a new chemical synthesis facility that will enable the return of API production for select neuroscience, immunology, and oncology products from Europe and Asia to the U.S.

AbbVie Inc. (NYSE:ABBV) is a global biopharmaceutical company focused on discovering and developing targeted therapies for blood cancers and solid tumors. Its oncology portfolio and research pipeline heavily feature antibody-drug conjugates (ADCs), targeted protein degradation, CAR-T cell therapies, and bispecific antibodies.

While we acknowledge the potential of ABBV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 13 Best Manufacturing Stocks to Invest In Now and 11 AI Stocks That Will Go to the Moon.

Disclosure: None.  Follow Insider Monkey on Google News.